In addition, the PKA fusion oncoprotein DnaJB1-PKAcat, associated with fibrolamellar carcinoma (FLC), undergoes aberrant LLPS through its prion-like domain, hijacking the regulatory subunit Riα and preventing its degradation. The gene discussed is DNAJB1; the disease is fibrolamellar hepatocellular carcinoma.